Eckert & Ziegler, DE0005659700

Eckert & Ziegler stock stabilizes after 52-week low and modest Xetra decline

Published on 09/09/2026 at 13:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eckert & Ziegler stock closed at EUR 12.51 on Xetra on September 8, 2026, down 0.56% from the prior session. The shares remain above the recent 52-week low of EUR 12.58 but below analyst targets between EUR 21.70 and 24.00.

Photorealistischer Reinraum einer radiopharmazeutischen Produktionsanlage
Eckert & Ziegler DE0005659700 Medizintechnik: Forscher arbeiten in modernem Radiopharmazeutika-Reinraum mit Gloveboxen und Hot-Cells, Illustration mit AI erstellt.

Eckert & Ziegler stock (ISIN DE0005659700) finished Xetra trading at EUR 12.51 on September 8, 2026, marking a 0.56% decline compared with the prior close and extending a phase of subdued performance for the medical technology mid cap.

Price action around the recent 52-week low

According to Xetra pricing data reported by a major financial portal on September 8, 2026, Eckert & Ziegler stock closed the session at EUR 12.51, with the previous close confirmed at EUR 12.58 and a day-on-day move of minus 0.56%.

The same snapshot shows that intraday trading remained narrow, with the Eckert & Ziegler share price fluctuating between a low near EUR 12.51 and a high just above EUR 12.58 on September 8, 2026, underscoring limited volatility despite the slight downward drift.

Stock level versus 52-week low and analyst targets

In early September 2026, Eckert & Ziegler stock touched a fresh 52-week low when it ended the Xetra session at EUR 12.58 on September 7, 2026, a move that highlighted persistent weakness in the share price relative to its trading range over the past year.

Subsequent indications from a leading charting platform in early September 2026 pointed to a recovery phase, with Eckert & Ziegler stock trading notably above the EUR 12.58 bottom at one point, while the company’s market capitalization was described as near EUR 1.09 billion as of that snapshot, signaling that the market continues to assign a billion-euro valuation to the isotope specialist.

Analyst data compiled by a major market-data platform in early September 2026 show that coverage for Eckert & Ziegler stock currently centers on a price target corridor between EUR 21.70 and EUR 24.00, implying that, relative to the share price region around the mid-teens, the consensus still sees room for appreciation over the medium term.

Recent closing price and investor perspective

As of the completed Xetra session on September 8, 2026, Eckert & Ziegler stock stands at EUR 12.51, modestly below the EUR 12.58 level that marked the latest 52-week low, with trading volume on that day reported at 18,313 shares, illustrating relatively restrained turnover compared with more liquid German technology constituents.

Key data on Eckert & Ziegler stock

  • Company: Eckert & Ziegler AG
  • ISIN: DE0005659700
  • WKN: 565970
  • Ticker: EUZ
  • Trading venue: Xetra
  • Price (as of September 8, 2026): 12.51 EUR
  • Market capitalization: 1.09 billion EUR (as of early September 2026)
  • Sector / Industry: Health Care / Medical Technology
  • Index membership: TecDAX

More news and analyses on Eckert & Ziegler stock

Disclaimer...

en | DE0005659700 | ECKERT & ZIEGLER | boerse | 70075026 | bgmi